Literature DB >> 22185868

Myocarditis.

Sandeep Sagar1, Peter P Liu, Leslie T Cooper.   

Abstract

Myocarditis is an underdiagnosed cause of acute heart failure, sudden death, and chronic dilated cardiomyopathy. In developed countries, viral infections commonly cause myocarditis; however, in the developing world, rheumatic carditis, Trypanosoma cruzi, and bacterial infections such as diphtheria still contribute to the global burden of the disease. The short-term prognosis of acute myocarditis is usually good, but varies widely by cause. Those patients who initially recover might develop recurrent dilated cardiomyopathy and heart failure, sometimes years later. Because myocarditis presents with non-specific symptoms including chest pain, dyspnoea, and palpitations, it often mimics more common disorders such as coronary artery disease. In some patients, cardiac MRI and endomyocardial biopsy can help identify myocarditis, predict risk of cardiovascular events, and guide treatment. Finding effective therapies has been challenging because the pathogenesis of chronic dilated cardiomyopathy after viral myocarditis is complex and determined by host and viral genetics as well as environmental factors. Findings from recent clinical trials suggest that some patients with chronic inflammatory cardiomyopathy have a progressive clinical course despite standard medical care and might improve with a short course of immunosuppression. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22185868      PMCID: PMC5814111          DOI: 10.1016/S0140-6736(11)60648-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  95 in total

1.  Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results.

Authors:  R Wojnicz; E Nowalany-Kozielska; C Wojciechowska; G Glanowska; P Wilczewski; T Niklewski; M Zembala; L Polonski; M M Rozek; J Wodniecki
Journal:  Circulation       Date:  2001-07-03       Impact factor: 29.690

2.  Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions.

Authors:  Carolyn B Coyne; Jeffrey M Bergelson
Journal:  Cell       Date:  2006-01-13       Impact factor: 41.582

3.  Serologic prevalence of coxsackievirus group B in Greece.

Authors:  M D Mavrouli; N Spanakis; S Levidiotou; C Politi; S Alexiou; P Tseliou; M Hatzitaki; K Foundouli; A Tsakris; N J Legakis; J G Routsias
Journal:  Viral Immunol       Date:  2007       Impact factor: 2.257

4.  Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators.

Authors:  L T Cooper; G J Berry; R Shabetai
Journal:  N Engl J Med       Date:  1997-06-26       Impact factor: 91.245

Review 5.  Clinical aspects of the Chagas' heart disease.

Authors:  Gopikrishna Punukollu; Ramesh M Gowda; Ijaz A Khan; Victor S Navarro; Balendu C Vasavada
Journal:  Int J Cardiol       Date:  2007-02-14       Impact factor: 4.164

6.  Transcriptomic biomarkers for the accurate diagnosis of myocarditis.

Authors:  Bettina Heidecker; Michelle M Kittleson; Edward K Kasper; Ilan S Wittstein; Hunter C Champion; Stuart D Russell; Ralph H Hruban; E Rene Rodriguez; Kenneth L Baughman; Joshua M Hare
Journal:  Circulation       Date:  2011-03-07       Impact factor: 29.690

7.  Endomyocardial biopsy findings in 50 patients with idiopathic atrioventricular block: presence of myocarditis.

Authors:  A Uemura; S Morimoto; S Hiramitsu; H Hishida
Journal:  Jpn Heart J       Date:  2001-11

8.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.

Authors:  J W Mason; J B O'Connell; A Herskowitz; N R Rose; B M McManus; M E Billingham; T E Moon
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

Review 9.  Eosinophilic myocarditis temporally associated with conjugate meningococcal C and hepatitis B vaccines in children.

Authors:  Michelle Barton; Yaron Finkelstein; Mary Anne Opavsky; Shinya Ito; Tommy Ho; Lee E Ford-Jones; Glenn Taylor; Lee Benson; Ronald Gold
Journal:  Pediatr Infect Dis J       Date:  2008-09       Impact factor: 2.129

10.  Lyme carditis in children: presentation, predictive factors, and clinical course.

Authors:  John M Costello; Mark E Alexander; Karla M Greco; Antonio R Perez-Atayde; Peter C Laussen
Journal:  Pediatrics       Date:  2009-05       Impact factor: 7.124

View more
  185 in total

1.  Silencing of CCR2 in myocarditis.

Authors:  Florian Leuschner; Gabriel Courties; Partha Dutta; Luke J Mortensen; Rostic Gorbatov; Brena Sena; Tatiana I Novobrantseva; Anna Borodovsky; Kevin Fitzgerald; Victor Koteliansky; Yoshiko Iwamoto; Marina Bohlender; Soeren Meyer; Felix Lasitschka; Benjamin Meder; Hugo A Katus; Charles Lin; Peter Libby; Filip K Swirski; Daniel G Anderson; Ralph Weissleder; Matthias Nahrendorf
Journal:  Eur Heart J       Date:  2014-06-20       Impact factor: 29.983

2.  Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response.

Authors:  Lianhua Yan; Fen Hu; Xiaofei Yan; Yuzhen Wei; Wenhan Ma; Ya Wang; Shuai Lu; Zhaohui Wang
Journal:  J Mol Med (Berl)       Date:  2016-04-06       Impact factor: 4.599

3.  Immunological and pathological consequences of coxsackievirus RNA persistence in the heart.

Authors:  Claudia T Flynn; Taishi Kimura; Kwesi Frimpong-Boateng; Stephanie Harkins; J Lindsay Whitton
Journal:  Virology       Date:  2017-12       Impact factor: 3.616

4.  The Brazilian Society of Cardiology and Brazilian Society of Exercise and Sports Medicine Updated Guidelines for Sports and Exercise Cardiology - 2019.

Authors:  Nabil Ghorayeb; Ricardo Stein; Daniel Jogaib Daher; Anderson Donelli da Silveira; Luiz Eduardo Fonteles Ritt; Daniel Fernando Pellegrino Dos Santos; Ana Paula Rennó Sierra; Artur Haddad Herdy; Claúdio Gil Soares de Araújo; Cléa Simone Sabino de Souza Colombo; Daniel Arkader Kopiler; Filipe Ferrari Ribeiro de Lacerda; José Kawazoe Lazzoli; Luciana Diniz Nagem Janot de Matos; Marcelo Bichels Leitão; Ricardo Contesini Francisco; Rodrigo Otávio Bougleux Alô; Sérgio Timerman; Tales de Carvalho; Thiago Ghorayeb Garcia
Journal:  Arq Bras Cardiol       Date:  2019-03       Impact factor: 2.000

5.  Three immune-mediated disease models induced by Theiler's virus: Multiple sclerosis, seizures and myocarditis.

Authors:  Ikuo Tsunoda; Fumitaka Sato; Seiichi Omura; Mitsugu Fujita; Namie Sakiyama; Ah-Mee Park
Journal:  Clin Exp Neuroimmunol       Date:  2016-10-25

6.  Therapeutic recommendations were non-specific.

Authors:  Ulf Müller-Ladner
Journal:  Dtsch Arztebl Int       Date:  2012-11-02       Impact factor: 5.594

Review 7.  Astragalus membranaceus injection combined with conventional treatment for viral myocarditis: a systematic review of randomized controlled trials.

Authors:  Yuan-lin Piao; Xiao-chun Liang
Journal:  Chin J Integr Med       Date:  2014-08-06       Impact factor: 1.978

8.  Acute myocarditis following administration of BNT162b2 vaccine.

Authors:  Mhd Baraa Habib; Tahseen Hamamyh; Ahmed Elyas; Mohammed Altermanini; Mawahib Elhassan
Journal:  IDCases       Date:  2021-06-16

9.  In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease.

Authors:  Nadine Althof; Stephanie Harkins; Christopher C Kemball; Claudia T Flynn; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

Review 10.  Sex and gender differences in myocarditis and dilated cardiomyopathy.

Authors:  DeLisa Fairweather; Leslie T Cooper; Lori A Blauwet
Journal:  Curr Probl Cardiol       Date:  2013-01       Impact factor: 5.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.